Home - Products - Others - Other Targets - 5-Amino-4-imidazolecarboxamide

5-Amino-4-imidazolecarboxamide

CAS No. 21299-72-9

5-Amino-4-imidazolecarboxamide( —— )

Catalog No. M13390 CAS No. 21299-72-9

An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
50MG 43 In Stock
100MG 56 In Stock
200MG 79 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    5-Amino-4-imidazolecarboxamide
  • Note
    Research use only, not for human use.
  • Brief Description
    An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC.
  • Description
    An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    21299-72-9
  • Formula Weight
    126.12
  • Molecular Formula
    C4H6N4O
  • Purity
    >98% (HPLC)
  • Solubility
    Limited solubility
  • SMILES
    Cl.NC(=O)C1=C(N)N=CN1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Velavan A, et al. Org Biomol Chem. 2012 Aug 21;10(31):6420-3
molnova catalog
related products
  • Periplogenin 3-[O-be...

    Periplogenin 3-[O-beta-glucopyranosyl-(1->4)-beta-sarmentopyranoside] is a natural product from Periploca sepiumBge.

  • Albendazole Oxide

    Albendazole is a tubulin polymerization or assembly inhibitor, used for the treatment of a variety of parasitic worm infestations.

  • Lucidumol A

    Lucidumol A has relatively good effect against aldose reductase with IC50 of 19.1uM. Lucidumol A has cytotoxic activity, it reduced cell growth in three human carcinoma cells (Caco-2, HepG2, and HeLa cells) dose dependently with LC50s from 20.87 to 84.36 uM.